Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

NCT04020198 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT04020198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04020198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies
Lead sponsor
Stony Brook University
Phase
Observational
Overall status
Terminated
Start date
January 15, 2020
Completion date
October 19, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy, normal pressure hydrocephalus, parkinson disease, rapid eye movement sleep behavior disorder